Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Aurora has problems 1,000,000,000 shares outtanding
By the end of fiscal 2014, Aurora's share count has ballooned from just over 16 million to around 950 million. With a number of existing convertible notes, stock options, and warrants still outstanding, it's almost assured that Aurora's share count will surpass 1 billion. Aside from weighing down existing shareholders for a long period of time, it also means that Aurora needs to generate CA$100 million just to produce CA$0.10 in earnings per share, which would still represent a nosebleed price-to-earnings ratio of 81.
In other words, Aurora may have clear-cut advantages and things to like, but it's sort of a nightmare from a fundamental and investing perspective.
In Canada, the requirements for novelty are codified under s. 28.2 of the Patent Act:[4]
“
28.2 (1) The subject-matter defined by a claim in an application for a patent in Canada (the "pending application") must not have been disclosed
(a) more than one year before the filing date by the applicant, or by a person who obtained knowledge, directly or indirectly, from the applicant, in such a manner that the subject-matter became available to the public in Canada or elsewhere;
(b) before the claim date by a person not mentioned in paragraph (a) in such a manner that the subject-matter became available to the public in Canada or elsewhere;
(c) in an application for a patent that is filed in Canada by a person other than the applicant, and has a filing date that is before the claim date;
...
”
The section does not restrict disclosure to prior patents, giving a broad description of what includes prior disclosure; so long as the subject-matter was disclosed "in such manner that the subject-matter became available to the public", the subject-matter is barred from being patented.[4] This may include prior patents, publications or the invention itself being put on display. Disclosures in a private document, such as an internal memo that is not available to the public, do not count.[5]
There is an eight-pronged test to determine whether anticipation occurs in Canada. The prior art must:
give an exact prior description;
give directions which will inevitably result in something within the claims;
give clear and unmistakable directions;
give information which for the purpose of practical utility is equal to that given by the subject patent;
convey information so that a person grappling with the same problem must be able to say "that gives me what I wish";
give information to a person of ordinary knowledge so that he must at once perceive the invention;
in the absence of explicit directions, teach an "inevitable result" which "can only be proved by experiments"; and
satisfy all these tests in a single document without making a mosaic.[6]
Non-obviousness
Also, RQ rep stated they do not currently have a patent on their Orbital Gardens. Whether or not they have one pending I have no idea.
I called IR yesterday they stated that there are 12 different companies that manufacture these rotational devices and they have been around for years. RavenQuest states in their literature they they have a proprietary ownership right to its devices:
“Proprietary
As a noun, a proprietor or owner; one who has the exclusive title to a thing; one who possesses or holds the title to a thing in his or her own right; one who possesses the dominion or ownership of a thing in his or her own right.
As an adjective, belonging to ownership; owned by a particular person; belonging or pertaining to a proprietor; relating to a certain owner or proprietor.
Proprietary refers to ownership or characteristics relating to ownership. It describes all the rights that the owner of property can exercise. Proprietary articles are items that are manufactured and marketed under an exclusive right.
Municipal corporations have a proprietary function, a term describing the duty or capacity of a city to enter into business ventures or to perform discretionary acts in the best interests of the citizens. Proprietary functions differ from governmental functions, which are duties that a city performs as a political subdivision of a state.
West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.”
Meaning that their device has a distinct difference from the rest in some manner. Also, we don’t know when Roto Gro’s patents expire. If in fact there are many companies manufacturing these devices then Roto Gro’s patents could be challenged not only by RavenQuest but also potentially by these 12 companies. The simplest difference can invalidate a patent. For instance, RavenQuest devices are stacked to increase production per sq. ft. That in itself could distinquish a difference between the two. Note the bold below
“While the basic technology of growing plants inside a rotating drum with a light source down the middle has been around for decades, we have taken this simple concept and added an enterprise overlay allowing for industrial scale production. This overlay includes a completely automated system, allowing one operator to control all of the grow variables remotely using a human-machine interface.
This automated garden system controls the nutrient levels, acidity, CO2, water levels, water temperature, lighting, rotational speed and dozens of other growing variables for optimized conditions. Our gardens have been engineered to produce cannabis in a near perfect growing environment.
We then stack the gardens three-high and two wide to form a cluster known internally as a “six-stack”:
Our internal testing shows that the Orbital Garden 2.0 system, which is commercially scalable, will result in production beginning at 300 grams per square foot (of live growing space), double or even triple the industry averages. Additional efficiencies include:
Up to 300 plants per garden
70%-80% reduction in electrical costs, 25% reduction in nutrient costs
HD remote crop monitoring
Remote automation also dramatically reduces human traffic into the grow-room, a known vector for plant infection.”
He cannot answer your question with verifiable facts. He believes you should be satisfied with hearsay from an anonymous source. Opinions are not facts and ones acceptance of opinons should be based upon reliability of sources. Lol.
Oh gosh, that sounds like they are very reliable. Regular contact you say, wow that is much different than just occasional contact. Lol.
Edmonton facility is having their Ornital Gardens installed.
Perhaps your source of information is the New York Times?
Conversation with who? Even though it may have the credibility of an anonymous source.
If you write something so controversial please provide a link. Hearsay, is not evidence.
RavenQuest BioMed
@RQBGlobal
·
Aug 23
“This is the second inning. The opportunity in front of us is immense.” - George Robinson, CEO RavenQuest BioMed, Live at the MONEYSHOW San Francisco
#acmpr
#cannabisact
#matijuanstocks
$rqb.c
$rvvqf
Very disturbing. You may want to consider being more positive about what cannabis does for you instead of displaying the negative effects since you are invested.
4000 Kilo production would equal $ 20 M. Problem is that currently they are only producing 2200 Kilo. RavenQuest bought this facility from another grower who had it set up for the standard flat table growing. I guess they had a choice to hold up all production to install their Orbital Garden, or to produce using other company’s system to get the facilities Certified by the Health dept. A full year of growing will only produce $ 11 M annually until they make the change over. I assume they had to wait to have the Orbital Gardens built before they could install them and thought it would be better to produce this way now rather than wait and produce nothing. AJMO and worth what you paid for it.
I am only concluding all of this by trying to interpret what the articles are saying. I prefer deliberate details but that is hardly ever what you get when investing. Considering that RQ cannot receive revenues until after 10/17/2018 and all of their facilities are not fullynoperational yet what should we expect from a company transitioning from a consultant to other growers to a grower and consultant. Once they initiate all of their current plans and are fully operational they will produce 51,000 kilos a year which equates to $255 M annually not even counting their consulting business and that is using the low figure of $ 5.00 per gram. Using $8 would equal $408 million. If production cannot meet demand then I would assume $8 per gram would be the norm. Who knows?
Also, from you.....”fully functioning at the end of 2018”. The figure I suggested was for ending 12/31/2018 not 2019.
“By the end of 2018, RavenQuest expects to be producing approx. 11,000 kilograms on an annual basis and will be able to capitalize on a market shortage. We are favorable on the capacity that will be coming online and will monitor how the team continues to execute.”
If that statement is accurate. That means that they expect to have the Obital Gardens installed at Bloomera by the end of this year and that they are currently producing at a rate of 2,200 kilo a year. How long they have been producing is anyone’s guess. I know that they had to have 2 harvest completed and tested to have the facility certified. Each grow cycle is eight weeks which is 6 per year. They should have 4 cycles done by the end of this year which is 2/3 rds of full capacity= .66 X 2,200 kilo= 1,452 kilo x $5.00 = $7,260,000 by the end of this year. AJMO and worth what you paid for it.
The above is for the Bloomera facility alone.
Not doubting your word, but it just doesn’t compute with other news releases. For instance, the current capacity of Bloomera facility is 2,200 kilograms/ 4000 when the Orbital Gardens are installed. The liquor board has requested to buy their complete production of Bloomera for the next 12 months. They are currently producing cannabis so by October next year at the latest that should equal at least $11 M revenue in cannabis production alone. How much they receive in consulting fees I have no idea. I was told over the telephone that next year they should have $55 M in cannabis production and $15 M in consulting fees for a total of $70 M. The Agripharma facility is suppose to be ready for production by the end of this year. I would check back with them to get confirmation on those numbers. They seem very low to me. AJMO and worth what you paid for it.
Also,
When you consider that B.C. liquor board has agreed to purchase all the production from the Bloomera facility for the next 12 months that entails a minimum of $10 M in revenues. So, that chart showing $3 M plus revenue for 2019 must be an old estimate leaving out several new developements.
I believe you may be in for a pleasant surprise when they make new revenue projections
AJMO and worth what you paid for it.
I don't see how that is very accurate since they are expected to produce 55 M through the 2 facilities they currently have up and running by producing a combined 11k kilograms annually. That in itself equates to $55 M in revenue. Then the addition of any consulting fees they acquire, which should be significantly more than they cuurently receive because of the addition of large orders through Alexander Nations, and Fort McMurray projects.
The 70 million you mention is total revenue from all operational facilities plus consulting fees. I am referring to total annual revenue from that one particular facility. 7,000,000 grams annual production X $5.00 per gram=$35,000,000 not $48,000,000. So I question where the additional $13,000,000 is coming from for that particular facility.
From Twitter:
“On Aug. 10, a busload of people travelled from the First Nation community to tour a RavenQuest production facility in Edmonton. The one slated for Alexander will have some of the same features, including innovative technology used to grow the soon-to-be-legalized recreational drug.
That includes ditching the flat-table model – where potted plants grow skywards towards its light source – for orbital gardens. The gardens feature stacks of hollow drums where plants hang around a light source.
One garden – called the Orbital Garden 2.0 – can grow up to 300 grams of cannabis. The Edmonton RavenQuest Cannabis BioMed facility is expected to grow 7,000 kilograms of cannabis a year and generate around $48 million annually.”
————————————
That should really help the share price I would think. One thing that concerns me is this, I have concluded through other revenue estimates using sq. footage and kilograms produced that RQ was receiving $ 5.00 per gram. If that is correct then this facility should produce $35 million annually not $ 48 million unless they are adding $13 million more profits due to selling through their not yet completed retail facility in Edmonton, in which case they would yield greater profit. AJMO and worth what you paid for it.
RavenQuest Signs Services Contract With Alexander First Nation
GlobeNewswire•August 15, 2018
VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) is pleased to announce it has entered into a services agreement with Alexander First Nation to develop a Health Canada cannabis license application. Alexander First Nation is located adjacent to the Edmonton Metropolitan Region and plans to build a cannabis facility on its sovereign land.
“We are genuinely excited to be working with Alexander First Nation,” stated George Robinson, CEO of RavenQuest. “Today’s announcement marks the beginning of a trusting and mutually beneficial relationship. We’ve taken a huge first step toward a brighter economic future for both Alexander First Nation and RavenQuest,” said Robinson.
“This agreement speaks to our continued commitment to working with Indigenous communities,” Robinson continued. “We see the economic and social impact these partnerships can bring and will continue our work in earnest to establish similar partnerships and engagements with unique Indigenous communities in the months ahead.”
RavenQuest Is An Undervalued Opportunity With Several Levers For Growth
August 9, 2018
Last month, we highlighted RavenQuest BioMed (RQB.CN) (RVVQF) as an undervalued Canadian cannabis producer. This came after a significant decline and we are favorable on the recent move higher.
Although the shares have come off their lows, we still consider the shares to be attractive as a long-term play. RavenQuest represents a differentiated opportunity due to its unique grow methodologies, the relationships it has with Fort McMurray First Nation #468 as well as the research partnership with McGill University.
Posited to Capitalize on a Burgeoning Market
The Canadian cannabis producer is in the middle of a major expansion and we are bullish on this. Once construction is completed, RavenQuest will able to produce approx. 51,000 kilograms a year. The existing properties have significant room to expand and we consider this to be a long-term growth driver for the company.
RavenQuest will be well positioned to capitalize on an undersupplied Canadian cannabis market. In October, Canada’s recreational marijuana market will open and this will create a major supply-demand issue. We expect to see a very undersupplied market, especially early on, and this will benefit producers like RavenQuest.
Although RavenQuest will not be a major producer early on, we are favorable on the growth trajectory. By the end of 2018, RavenQuest expects to be producing approx. 11,000 kilograms on an annual basis and will be able to capitalize on a market shortage. We are favorable on the capacity that will be coming online and will monitor how the team continues to execute.
RavenQuest has several levers for growth and this is an exciting aspect of the story. The management team has been working tirelessly, making sure that the company will hit its targets and projections. We are favorable on the management team’s ability to execute and will be monitoring this one.
An Significant Relationship with Fort McMurray First Nation #468
Last year, RavenQuest signed an agreement with Fort McMurray First Nation #468 to build a 24,000 sq. ft. facility. We are favorable on this relationship and view it as an attractive growth driver for the company. Over the next year, we expect the company to secure agreements with other Indigenous nations which will create catalysts.
On top of the increased production capacity, the relationship with the Indigenous nation adds a significant distribution network. We expect the agreement to open up new distribution outlets for RavenQuest and view this as an attractive aspect of the relationship.
We consider this relationship to be a future growth drive and are monitoring how this will add value to the overall business. The improved capacity and distribution are key value drivers and we will watch how the team executes on this.
An Undervalued Opportunity with Several Levers for Growth
RavenQuest is able to create value through its consulting/management services division. The company serves as a key adviser to extensive and reputable list of clients and provides end-to-end solutions for existing LPs and late-stage ACMPR applicant. The company is already generating revenue and producing positive cash flows through its services division.
We are favorable on the ability to generate revenue while waiting to complete a major buildout. This division sells proprietary, automated systems for growing, drying, monitoring designed specifically for cannabis yield maximization and delivers comprehensive, integrated solutions to cannabis companies.
When compared to other Canadian cannabis producers, RavenQuest is very undervalued and we are favorable on this due to the company’s value proposition. RavenQuest has a multi-faceted growth strategy that helps de-risk the business plan. We are monitoring how the team continues to execute and how the shares trade from here.
To learn more about RavenQuest and receive a free report email support@technical420.com
Authored by Anthony Varrell
Search Articles
RavenQuest Is An Undervalued Opportunity With Several Levers For Growth
RavenQuest Eyes Massive Micro Cultivation Market
http://www.cannabisfn.com/ravenquest-eyes-massive-micro-cultivation-market/
Ryan Allway
June 29th, 2018
Exclusive, News, Top News
Canada recently passed the Cannabis Act and full federal legalization is finally set to happen in mid-October. Licensed producers have been working to scale up their production, but relatively few investors are familiar with micro-cultivation.
RavenQuest BioMed Inc. (CSE: RQB) aims to help micro-cultivators move from the black market into the legal ACMPR framework in exchange for equity and/or royalty agreements. Investors may want to take a closer look at the stock after the company signed its first letter of intent in the space to prove out the business model.
Micro Cultivation & Processing
The Government of Canada introduced Bill C-45 — better known as the Cannabis Act — in April 2017 to legalize and regulate cannabis throughout the country. After passing the Senate this week, the bill will be signed into law following the Royal Assent and Prime Minister Justin Trudeau expects cannabis to be fully legalized on October 17 — a slight delay from the anticipated July launch date.
A little-known element of Bill C-45 is the introduction of micro-cultivation and processing as a means to produce cannabis. This license category is designed to enable the participation of small-scale growers in the legal cannabis industry by authorizing the same activities as a license for standard cultivation at a smaller scale.
The final draft of the bill cited the following requirements:
Micro cultivation permits would authorize a canopy area of no more than 200 square meters — or 2,153 square feet.
Micro processing permits would permit the processing of no more than 600 kilograms — or 13,228 pounds — of dried cannabis per year, or the entire output of a single micro-cultivation license.
The government’s intent with these micro-cultivation licenses is to bring former MMAR and compassionate-use producers into the legal fold. With limited resources and a small production footprint, many of these cannabis producers operate in the black market and outside of the scope of the ACMPR. The government hopes to bring these producers into the legal realm and help them comply with the new laws.
RavenQuest Acquires Elephant Extracts
RavenQuest BioMed Inc. (CSE: RQB) recently announced a letter of intent to acquire a majority 51 percent equity stake in Elephant Extracts, a license applicant under the ACMPR and a distributor of cannabis products and accessories. The company owns a. production facility that will be classified as a “micro cultivator” license upon passing of the Cannabis Act in Canada — meaning it could produce up to 600 kilograms per year.
“RavenQuest is committed to helping micro cultivators come into the legalized space across the country,” said CEO George Robinson. “We expect this will be the first of many micro cultivators to work with RavenQuest. Our services division, which has helped several LPs become licensed, brings an expertise which is unmatched in the cannabis space. Our experience in this highly regulated space brings precisely what is needed by the many micro cultivators who wish to properly transition to the legalized space.”
Under the terms of the agreement, RavenQuest BioMed would receive a controlling 51 percent interest in the company that can be redeemed at any time after it receives a license to produce under the ACMPR. The company will also be granted an ongoing royalty of 15 percent of the gross revenue from production at the facility developed by Elephant Extract. The transaction is subject to due diligence and other considerations before being executed.
The company’s goal is to help a select group from these thousands of these smaller producers move into the legal market through the micro-cultivation license option. Because of its consulting division and lengthy experience in this area, RavenQuest is uniquely qualified to do just that. In addition to helping them navigate the legal requirements, RavenQuest BioMed offers these companies access to its breakthrough cannabis cultivation technologies including the Orbital Garden 2.0. These technologies can help micro-cultivators greatly increase their production from the limited footprint that they’re permitted.
Looking Ahead
Micro-cultivation will play a big role in the newly legalized cannabis market. For a historical comparison, consider the fact that tobacco companies leveraged small producers to meet tremendous demand early in that industry’s formation. These same dynamics are true in the cannabis industry where standard licensed producers will have trouble meeting the significant demand for cannabis following recreational legalization.
RavenQuest BioMed Inc. (CSE: RQB) is well positioned to capitalize on these dynamics by working with micro-cultivators. In exchange for its expertise, the company could gain access to a combination of equity and royalty payments from these smaller producers.
For more information, visit the company’s website at www.rqbglobal.com.
Ontario to allow private retailers to sell cannabis, report says
Facebook
Twitter
Government will still control the distribution, manage online sales
The Canadian Press · Posted: Jul 27, 2018 7:05 AM ET | Last Updated: 4 hours ago
(Remember the BC liquor board buying all of Boomera's 12 month supply)
The anticipated move by the newly elected PC government is a major reversal of the policy developed by the previous Liberal regime. (Ron Ward/Canadian Press )
50 comments
The Ontario government will reportedly allow private stores to sell marijuana once recreational cannabis becomes legal on Oct. 17.
A source in the provincial government told the Globe and Mail that Finance Minister Vic Fedeli and Attorney General Caroline Mulroney are expected to make an announcement as early as next week to outline a plan to let the private sector own and operate cannabis shops.
The source, who spoke on condition of not being identified, also indicated that the government would still control the distribution of the product to the stores and manage online sales.
Questions swirl around Ontario's pot plans as Doug Ford prepares to take power
Trudeau says pot will be legal as of Oct. 17, 2018
The previous Liberal government under Kathleen Wynne had planned to give the Liquor Control Board of Ontario a monopoly on the sale of recreational cannabis, with 40 stores slated to open this year under an LCBO subsidiary called the Ontario Cannabis Store (OCS).
The new system would mirror the Alberta model, which will allow for privately run cannabis stores to sell marijuana with licences granted by the liquor commission.
Ontario Premier Doug Ford has already indicated that he was considering the private sector, saying in late June that he doesn't believe "government should stick their nose into everything."
A spokesman for the Ontario Ministry of Finance wouldn't comment on the details but said the province will be ready by the time marijuana is legal in October.
CBC's Journalistic Standards and Practices
----------------
Sales will take-off out of the gate. Lets hope RQ gets more than its share. Things will start looking better come this fall. AJMO and worth what you aid for it.
From Twitter:
“RavenQuest: An Undervalued Opportunity
Over the last month, RavenQuest Biomed Inc. (RQB.CN) (RVVQF) has been under considerable pressure and this decline makes the company a stock to watch. RavenQuest BioMed represents an attractive and differentiated Canadian cannabis company that is in the middle of a major growth cycle.
Ravenquest is in the middle of a major expansion and will be well positioned to capitalize on an undersupplied Canadian cannabis market. In October, Canada’s recreational marijuana market will open and this will create a major supply-demand issue. Ravenquest expects to be producing approx. 11,00 kilograms on an annual basis by the end of the year and will be able to capitalize on a market shortage.
The Canadian cannabis producer is led by a management team with a proven track record of success and who are recognized leaders in the cannabis industry. This is an important aspect of the story and we are confident in their ability to execute and create value for shareholders.
When compared to other Canadian cannabis producers, Ravenquest is very undervalued. The company has a multi-faceted growth strategy and we are favorable on this as it helps de-risk the business plan. We are favorable on the valuation and this is a stock that we will continue to monitor.”
I checked marketwatch and they detailed 95.54 M shares outstanding if true the SP could instead be in the .70's. AJMO. Unfortunately Rq is in an expansion (spending phase ) with no reported invrease in income as of yet. Good luck.
First it depends the number of outstanding shares. If the correct number is 66 M then at the very least approximately
$1.05 TO $1.15 U.S. And that is without a multiple being applied. Some stocks trade at multiples of 15. A multiple like that would put us at $15. It all depends on market sentiment and confidence. $70 M IS quite a significant jump for RavenQuest and as these new facilties come on line and RavenQuest earnings expectations grow signicantly who knows what can happen? Unless RavenQuest does something stupid to screw it up it may be very intetesting to watch. AJMO and worth what you paid for it.
Where did you get your information for 92 million shares outstanding. I checked at the canadian stock exchange site and they list it as:
Capitalization
Issued & Outstanding: 66,613,612
Reserved for Issuance: 5,657,206
Just curious because i can't find 92 M anywhere.
“Since that time, we have been growing at a rapid pace. We became a Licensed Producer with the acquisition of Bloomera Inc. in early 2018. We also announced a joint venture to build a 50,000 kg/yr production facility with Fort McMurray First Nation #468 in Alberta.
In addition, we announced the acquisition of Western Agripharma Ltd., located off the coast of Vancouver, British Columbia.
At full build-out these projects will result in over 50,000 kg of annual cannabis production, with 11,000 kg funded and ready to go for legalization this fall.”
—————-
Note bold: equals 11,000,000 gram @ $5.00 per gram = $55,000,000 in Cannabis sales this year plus $15,000,000 in consulting business should equate to $70,000,000 in total income to RavenQuest this year. The 11 ,000,000 is from the Bloomera facility which has sold all its annual production already.
AJMO and worth what you paid for it.
Sorry for your loss,
I look at it like this:
$ 10,000,000.......from Bloomera sales
$ 15,000,000......from consulting business
S. 45,000,000..... from two other facilities
—————-
$ 70,000,000.......total income projected
With no multiples that is slightly over $1.00 per S/P
I am going to wait it out. AJMO and worth what you paid for it.
The current S/P is based on a current market cap of $ 25-29 million. It should become much more than that by years end. Right now only the consulting business and Bloomera are being credited by the market. And of course the outstanding shares have bloated to approximately 66 M shares because of borrowing money through selling warrants, but it seems so far they are using that money wisely. Good luck to you.
https://thecse.com/en/listings/life-sciences/ravenquest-biomed-inc
Capitalization
Issued & Outstanding: 66,613,612
Reserved for Issuance: 5,657,206
Does anyone know the correct number of outstanding shares? I am not certain if the above is correct.
Also,
Volume has significantly increased, but the share price levels, or goes down. Doesn’t matter if it is at the bid or ask. Very controlled action, someone has to pay for that to happen. When retail wants to buy thousands of shares the price goes up. Not exactly a level playing field. To get ahead retail has to be smarter, know when to hold, and know when to fold. So in conclusion, for some the same game is investing, and for others it is gambling. It brings great pleasure for me to (eventually) beat the House, I just have to work much harder at my due diligence and stick to it by waiting out some of the highs and all of the lows and know the difference by trying to judge what the big money does and not become a victim. AJMO, and worth what you paid for it.
Confidence builder, if one needs it.
————————-
“We are thrilled to see that the offering was oversubscribed, demonstrating the high-level of confidence that the market has in our Company’s unique combination of innovation, strategic vision and execution” stated George Robinson, Chief Executive Officer of RavenQuest. “Having successfully unveiled our Orbital Garden grow-methodology to the marketplace and announced an MOU to sell all of our Bloomera production to BCLDB, we feel we have significantly de-risked our story, representing a tremendous opportunity for our shareholders” Robinson continued.
Seems that RQ is getting approximately $5.00 per gram. I base that on an older article stating that RQ could produce 11,000K grams per year which would generate $55,000,000 in income. If that is true and the Bloomers facility could produce 2,000K grams that would mean that RQ with this contract is worth $10,000,000 over there consulting business. That is about $25,000,000. Nice start eh.
Bloomera is sold out for the next 12 months. Excellent.
ER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (RVVQF) (1IT.F) (the “Company” or “RavenQuest”) is pleased to announce that its wholly owned subsidiary, Bloomera Inc. (“Bloomera”), has signed a memorandum of understanding (the “MOU”) with the British Columbia Liquor Distribution Branch (“BCLDB”) to pursue the wholesale distribution of cannabis produced by Bloomera. It is expected that the agreement to be reached with BCLDB will cover the first 12 months of the legalized adult use cannabis market in Canada and see Bloomera sell all of its production over that period to the BCLDB. The MOU provides that Bloomera will supply a broad assortment of cultivars and end products to the BCLDB.
The BCLDB is responsible for regulating private retail cannabis licensing and the distribution of cannabis to retail stores in British Columbia’s legal adult use recreational cannabis marketplace. The MOU does not represent a binding purchase agreement, and any distribution of cannabis products to the BCLDB is subject to the negotiation of such an agreement on the terms specified by the BCLDB. The Company will provide additional information regarding the BCLDB supply and distribution process as it becomes available.
“We are delighted to be working with the BCLDB in pursuit of providing British Columbians with the premium quality cannabis that will come out of our Bloomera facility,” stated George Robinson, CEO of RavenQuest. “Word is getting out that RavenQuest’s grow methodologies are unparalleled in the industry. We have a deep relationship and understanding of the cannabis plant and the science that goes into delivering high quality and repeatable client experiences. This sets us apart as an organization and is about to be appreciated by the consumer as our exceptional cannabis reaches store shelves across British Columbia. We couldn’t be happier to be working with the BCLDB, which has been a tremendous group to work with throughout the negotiation process,” Robinson continued.
Great News
RavenQuest Signs Memorandum of Understanding to Supply British Columbia Liquor Distribution Branch (BCLDB)
GlobeNewswireJuly 11, 2018, 2:38 PM EDT
VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (RVVQF) (1IT.F) (the “Company” or “RavenQuest”) is pleased to announce that its wholly owned subsidiary, Bloomera Inc. (“Bloomera”), has signed a memorandum of understanding (the “MOU”) with the British Columbia Liquor Distribution Branch (“BCLDB”) to pursue the wholesale distribution of cannabis produced by Bloomera. It is expected that the agreement to be reached with BCLDB will cover the first 12 months of the legalized adult use cannabis market in Canada and see Bloomera sell all of its production over that period to the BCLDB. The MOU provides that Bloomera will supply a broad assortment of cultivars and end products to the BCLDB.
The BCLDB is responsible for regulating private retail cannabis licensing and the distribution of cannabis to retail stores in British Columbia’s legal adult use recreational cannabis marketplace. The MOU does not represent a binding purchase agreement, and any distribution of cannabis products to the BCLDB is subject to the negotiation of such an agreement on the terms specified by the BCLDB. The Company will provide additional information regarding the BCLDB supply and distribution process as it becomes available.
“We are delighted to be working with the BCLDB in pursuit of providing British Columbians with the premium quality cannabis that will come out of our Bloomera facility,” stated George Robinson, CEO of RavenQuest. “Word is getting out that RavenQuest’s grow methodologies are unparalleled in the industry. We have a deep relationship and understanding of the cannabis plant and the science that goes into delivering high quality and repeatable client experiences. This sets us apart as an organization and is about to be appreciated by the consumer as our exceptional cannabis reaches store shelves across British Columbia. We couldn’t be happier to be working with the BCLDB, which has been a tremendous group to work with throughout the negotiation process,” Robinson continued.
Very disappointed, but still hanging in there. Waiting for this to turn around. I thought the mid .60’s would be the lows it seems that those with big money to invest are being given an outstanding opportunity with little to no resistance. I believed, and still do, that this company has everything going for it to become very successful, I just wish I would have waited longer to test its past performance levels. Seems that 7/6/2018 was a setup by those pushing the stock. In the back of my mind I wondered about that, seems the back of my brain works better than the front and I should listen to it more often. Oh well, live and learn. GLTA.
P.S. an overall update by the company including licensing activities and expectations would be somewhat helpful. Perhaps there are not enough small retail investors left to really care about it. Oh well, I am prepared to go down in flames....no flames, no glory. Lol.
6/29/2018
Symbol Last Volume
RQB:CNX0 .71 608.60k
,71 cent Canadian= .5325 U.S. ( .75×.71 =.5325)
This what they did on the Canadian stock exchange Friday. Lot more volume. S/P about the same.